Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System.

Archives of pathology & laboratory medicine - 1 Sept 2015

Brat Daniel J, Cagle Philip T, Dillon Deborah A, Hattab Eyas M, McLendon Roger E, Miller Margaret A, Buckner Jan C

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Central Nervous System Neoplasms
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Tumor Suppressor

Share to Glioma

Share to Immunohistochemistry

Share to Neoplasms, Germ Cell and Embryonal

Share to Oncogenes

Source

Identifiers

PMID: 25642959
DOI: 10.5858/arpa.2014-0588-CP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System.PMID 25642959Read ↗

Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum.Semantic proximity Read ↗

Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.Semantic proximity Read ↗

Use of personalized molecular biomarkers in the clinical care of adults with glioblastomasSemantic proximity Read ↗

Evaluating the clinical utility of genomic profiling using cerebrospinal fluid to inform treatment and management of central nervous system tumors – a Meta Analysis of the literatureSemantic proximity Read ↗

Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.Semantic proximity Read ↗

What Every Neuropathologist Needs to Know: Practical Aspects and Pitfalls in Molecular Diagnosis of Brain Tumors.Semantic proximity Read ↗

cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnosticsSemantic proximity Read ↗

Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system.Semantic proximity Read ↗

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.Semantic proximity Read ↗

Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.Semantic proximity Read ↗

The Quest for Non-Invasive Diagnosis: A Review of Liquid Biopsy in GlioblastomaSemantic proximity Read ↗

Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.